Phase 3 clinical trials demonstrated a strong therapeutic response for a treatment targeting hidradenitis suppurativa.
2 reports, 2 independent
Updated Jun 21
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Phase 3 clinical trials demonstrated a strong therapeutic response for a treatment targeting hidradenitis suppurativa.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.BLA submission expected by end of September 2026 for HS therapy.1 source
Phase 3 trials showed strong therapeutic response for a treatment related to hidradenitis suppurativa.1 source
Keep exploring
The entities involved
-
SLK
Nothing else this week.